{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:20:21Z","timestamp":1791933621001,"version":"4.3.4"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/cid\/ciy567","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T08:50:15Z","timestamp":1530953415000},"page":"688-698","source":"Crossref","is-referenced-by-count":53,"title":["Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus\u2013infected Adults With CD4 Cell Counts <100\/\u03bcL: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-6555","authenticated-orcid":false,"given":"Elvis","family":"Temfack","sequence":"first","affiliation":[{"name":"Internal Medicine Unit, Douala General Hospital, Cameroon"},{"name":"Institut Pasteur of Paris, CNRS, Molecular Mycology Unit UMR 2000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Joel","family":"Bigna","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, Yaound\u00e9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry N","family":"Luma","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Douala General Hospital, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Spijker","sequence":"additional","affiliation":[{"name":"Cochrane Netherlands, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[{"name":"Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N","family":"Jarvis","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"},{"name":"Botswana Harvard AIDS Institute Partnership"},{"name":"Botswana-UPenn Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Dromer","sequence":"additional","affiliation":[{"name":"Institut Pasteur of Paris, CNRS, Molecular Mycology Unit UMR 2000, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harrison","sequence":"additional","affiliation":[{"name":"Institute of Infection and Immunity, St. George\u2019s University of London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie F","family":"Cohen","sequence":"additional","affiliation":[{"name":"INSERM UMR 1153 and Department of Pediatrics, Necker Hospital, AP-HP, Paris Descartes University"},{"name":"Paris Descartes University, Necker Pasteur Center for Infectious Diseases and Tropical Medicine, H\u00f4pital Necker Enfants malades, AP-HP, IHU Imagine, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[{"name":"Institut Pasteur of Paris, CNRS, Molecular Mycology Unit UMR 2000, France"},{"name":"Paris Descartes University, Necker Pasteur Center for Infectious Diseases and Tropical Medicine, H\u00f4pital Necker Enfants malades, AP-HP, IHU Imagine, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"key":"key\n\t\t\t\t2019013123593036900_CIT0001","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0004","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2334-10-67","article-title":"Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases","volume":"10","author":"Jarvis","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11046-013-9710-8","article-title":"Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from 2004 to 2011","volume":"176","author":"Sow","year":"2013","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0007","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000","volume":"36","author":"Mirza","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0008","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","article-title":"Epidemiology of HIV-associated cryptococcosis in France (1985\u20132001): comparison of the pre- and post-HAART eras","volume":"18","author":"Dromer","year":"2004","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0009","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11046-008-9123-2","article-title":"Epidemiological profile of cryptococcal meningitis patients in Rio Grande do Sul, Brazil","volume":"166","author":"Leal","year":"2008","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0011","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/QAD.0b013e328352d1d8","article-title":"Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy","volume":"26","author":"Bamba","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0012","first-page":"481","article-title":"The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya","volume":"87","author":"Mdodo","year":"2010","journal-title":"East Afr Med J"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/1947-2714.117318","article-title":"Cryptococcal meningoencephalitis in human immunodeficiency virus\/acquired immunodeficiency syndrome in Douala, Cameroon: a cross sectional study","volume":"5","author":"Luma","year":"2013","journal-title":"N Am J Med Sci"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0014","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0015","volume-title":"Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings","author":"World Health Organization","year":"2008"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0016","first-page":"CD004773","article-title":"Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV","volume":"3","author":"Chang","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0017","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1473-3099(11)70252-3","article-title":"Prevention of AIDS-associated cryptococcosis in resource-poor areas","volume":"11","author":"Lortholary","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0018","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40475-015-0045-z","article-title":"Preventing cryptococcosis-shifting the paradigm in the era of highly active antiretroviral therapy","volume":"2","author":"Meya","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0020","volume-title":"Rapid advice: diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents, and children","author":"World Health Organization"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0021","volume-title":"CrAg LFA","author":"IMMY"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0022","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1097\/QAD.0000000000000872","article-title":"Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia","volume":"29","author":"Kapoor","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0023","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count \u2264100 cells\/\u00b5L who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0024","doi-asserted-by":"crossref","first-page":"e13856","DOI":"10.1371\/journal.pone.0013856","article-title":"Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia","volume":"5","author":"Micol","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0025","doi-asserted-by":"crossref","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa","volume":"8","author":"Jarvis","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0026","doi-asserted-by":"crossref","first-page":"e62213","DOI":"10.1371\/journal.pone.0062213","article-title":"Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program\u2014Vietnam","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0027","author":"Conseil National du Sida et des hepatites virales Prise en charge du VIH \u2013 Recommandations du groupe d\u2019experts"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0028","volume-title":"Joanna Briggs Institute reviewers\u2019 manual: 2016 edition","author":"Joanna Briggs Institute","year":"2016"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0029","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0030","volume-title":"The Cochrane Collaboration. Review Manager (RevMan). Version 5.3","author":"The Nordic Cochrane Centre","year":"2014"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002030-198902000-00004","article-title":"The value of cryptococcal serum antigen screening among HIV-positive\/AIDS patients in Kinshasa, Zaire","volume":"3","author":"Desmet","year":"1989","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0032","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0033","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jinf.2010.03.015","article-title":"The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts","volume":"60","author":"Pongsai","year":"2010","journal-title":"J Infect"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0034","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-3156.2010.02683.x","article-title":"Short communication: low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana","volume":"16","author":"Mamoojee","year":"2011","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0035","first-page":"206","article-title":"Cryptococcal antigenemia in HIV infected patients with a CD4 count \u2264100 cell mm-3","volume":"55","author":"Linares","year":"2012","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0036","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5001\/omj.2012.51","article-title":"Screening for cryptococcal antigenemia in anti-retroviral naive AIDS patients in Benin city, Nigeria","volume":"27","author":"Osazuwa","year":"2012","journal-title":"Oman Med J"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0037","doi-asserted-by":"crossref","first-page":"18821","DOI":"10.7448\/IAS.17.1.18821","article-title":"Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia","volume":"17","author":"Ganiem","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0038","first-page":"585","article-title":"Prevalence and correlates of cryptococcal antigen positivity among AIDS patients\u2014United States, 1986\u20132012","volume":"63","author":"McKenney","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0039","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/cid\/civ559","article-title":"Cryptococcal antigen screening and preemptive treatment in a US cohort of patients with AIDS","volume":"61","author":"Manabe","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0040","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0041","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/QAI.0000000000000527","article-title":"Implementation and operational research: integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia","volume":"68","author":"Pac","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0042","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/2325957415592475","article-title":"Feasibility and acceptability of cryptococcal antigen screening and prevalence of cryptocococcemia in patients attending a resource-limited HIV\/AIDS clinic in Malawi","volume":"14","author":"Chipungu","year":"2015","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0043","first-page":"64","volume-title":"Pre-ART cryptococcal antigen titer associated with preemptive fluconazole failure","author":"Morawski","year":"2016"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0044","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/QAI.0000000000000976","article-title":"Implementation and operational research: evaluation of a public-sector, provider-initiated cryptococcal antigen screening and treatment program, Western Cape, South Africa","volume":"72","author":"Vallabhaneni","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study","volume":"62","author":"Longley","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0046","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/QAI.0000000000001048","article-title":"Brief report: geographical variation in prevalence of cryptococcal antigenemia among HIV-infected, treatment-naive patients in Nigeria: a multicenter cross-sectional study","volume":"73","author":"Ezeanolue","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0047","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.mycmed.2016.08.007","article-title":"Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou\/Benin","volume":"26","author":"Ogouy\u00e8mi-Hounto","year":"2016","journal-title":"J Mycol Med"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0048","doi-asserted-by":"crossref","first-page":"e0178721","DOI":"10.1371\/journal.pone.0178721","article-title":"Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay","volume":"12","author":"Frola","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0049","first-page":"119","article-title":"Prevalence of cryptococcal antigen positivity among HIV infected patient with CD4 cell count less than 100 of Imam Khomeini Hospital, Tehran, Iran","volume":"9","author":"Hajiabdolbaghi","year":"2017","journal-title":"Iran J Microbiol"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/ijmm.IJMM_15_596","article-title":"High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India","volume":"35","author":"Kadam","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0051","first-page":"317s","article-title":"High prevalence of CNS dissemination with asymptomatic cryptococcal antigenemia","volume":"25","author":"Makadzange","year":"2017","journal-title":"Top Antivir Med"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0052","doi-asserted-by":"crossref","first-page":"e0183656","DOI":"10.1371\/journal.pone.0183656","article-title":"Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: a feasibility study in rural Lesotho","volume":"12","author":"Rick","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0053","first-page":"316s","article-title":"Cryptococcal antigen screening among patients with advanced HIV infection in Vietnam","volume":"25","author":"Vu","year":"2017","journal-title":"Top Antivir Med"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0054","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAI.0000000000001669","article-title":"A prospective evaluation of a multisite cryptococcal screening and treatment program in HIV clinics in Uganda","volume":"78","author":"Nalintya","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fmicb.2018.00409","article-title":"Cryptococcal antigen screening in asymptomatic HIV-infected antiretroviral na\u00efve patients in Cameroon and evaluation of the new semi-quantitative Biosynex CryptoPS test","volume":"9","author":"Temfack","year":"2018","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0056","doi-asserted-by":"crossref","first-page":"18","DOI":"10.11604\/pamj.2018.29.18.14099","article-title":"Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau","volume":"29","author":"Thomsen","year":"2018","journal-title":"Pan Afr Med J"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0057","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cid\/cix872","article-title":"High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients","volume":"66","author":"Wake","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0058","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/cid\/cix1143","article-title":"CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis","volume":"66","author":"Ford","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0059","doi-asserted-by":"crossref","first-page":"e110285","DOI":"10.1371\/journal.pone.0110285","article-title":"A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi","volume":"9","author":"Gaskell","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0060","doi-asserted-by":"crossref","first-page":"e67311","DOI":"10.1371\/journal.pone.0067311","article-title":"A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi","volume":"8","author":"Rothe","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0061","doi-asserted-by":"crossref","first-page":"ofx274","DOI":"10.1093\/ofid\/ofx274","article-title":"Cryptococcal disease in the era of \u201ctest and treat\u201d: is there cause for concern","volume":"5","author":"Abassi","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0062","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0063","volume-title":"Test CryptoPS","author":"BIOSYNEX"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0064","doi-asserted-by":"crossref","first-page":"ofv046","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality","volume":"2","author":"Letang","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t2019013123593036900_CIT0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/cid\/civ939","article-title":"Editorial commentary: cryptococcosis in AIDS: new data but questions remain","volume":"62","author":"Jackson","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/4\/688\/27662775\/ciy567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T09:14:15Z","timestamp":1571562855000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/4\/688\/5055339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,7,18]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy567","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,15]]},"published":{"date-parts":[[2018,7,18]]}}}